Organizing Committee – ISCT 2021 New Orleans

Call for Abstract Submissions

Abstract submission now open • Submission Deadline: January 25^th, 2021

Join ISCT, the leading global society focused on the translation of cell and gene therapy, at the ISCT 2021 New Orleans VIRTUAL Meeting.

Why submit your abstract to ISCT 2021?

Global networking: Discuss your research with global leaders in translation science.
Publish your work: Accepted abstracts will be published in a special supplement of Cytotherapy, and many studies first presented at ISCT Annual Meetings go on to be published as full-length articles.
Present your research: Authors of outstanding abstracts will have the opportunity for LIVE Oral Abstracts, to present their research at the Annual Meeting.
Awards: $10,500 award funds to be won at ISCT 2021 New Orleans VIRTUAL:
- The Top Scoring Abstract Award ($1500 USD)
- Best Poster Award ($1500 USD)
- Early Stage Professional Awards ($1000 USD each, 3 available)
- Technologist Awards ($1000 USD each, 3 available)
- Top Scoring Emerging Economies Abstract Award ($1,000) – Sponsored by Cytotherapy
- ESP Rookie of the Year Award ($500 USD) – Sponsored by Cytotherapy

With record breaking attendance, ISCT 2020 Paris Virtual hosted over 2,000 experts from around the world. Abstracts presented at the event were viewed over 17,000 times. Don’t miss this opportunity to maximize the visibility and reach of your work.

Emphasizing the translational focus of ISCT, new abstract subcategories include:

Basic Science and Preclinical studies
Manufacturing and Regulatory
Clinical Investigation

ISCT 2021 New Orleans Virtual Abstract Categories:

Mesenchymal Stromal Cells
Hematopoietic Stem/Progenitor Cells
Immunotherapy
Exosomes
Embryonic stem cells, iPS and Related
Tissue Specific Stem Cells
Solid Organ Targeted Therapy
Tissue Engineering
Gene therapies
Process Development and Manufacturing
Regulatory Affairs, Quality Systems, Policy, and Ethics

Save The Date

Fill in this form to be added to our pre-event mailing list!
More information will be available soon through our websites, our e-mail distribution, and through social media.

ANNUAL MEETING GOES VIRTUAL

I am writing to share that ISCT has made the decision to host the ISCT 2021 New Orleans Annual Meeting in a virtual setting. While we very much look forward to the day we can gather again face to face, we continue to monitor the COVID-19 pandemic and have concluded that the most responsible course of action is to gather virtually for our 2021 Annual Meeting.

Both our Society and the entire cell and gene therapy field have shown remarkable resilience this year. You might have heard that ISCT 2020 Paris Virtual had record breaking attendance with over 2,000 delegates joining us from 60 countries. We have also experienced record-breaking ISCT membership growth this year and are now proud to represent more than 2,400 members from around the world.

In that spirit, and as we follow up on unprecedented growth, the New Orleans Virtual Meeting tagline has a slight twist to it: Re-Connect, Communicate, Translate. More than ever, we have a chance to broadcast the passion and excitement that characterizes our Society to one another, and to the global stage.

The ISCT 2021 Organizing Committee has kicked off development of the scientific program which will span 3 full live days, from May 26-28, 2021. This year, you can look forward to a full production showcasing sessions with world class scientific, regulatory and commercial experts, from the comfort of your home or office. With this are more opportunities than ever to showcase our corporate partners and advancements in the cell and gene therapy market through engaging presentations.

I’d like to thank all who responded to our 2021 pre-meeting survey. Networking with fellow delegates was identified as the most important motive for attending the 2021 Annual Meeting, and we’re already underway to deliver. We are working behind the scenes to set the bar even higher this year with new ways to engage with fellow meeting delegates in-platform and on social media.

More than ever, it’s important to stay connected.
Keep an eye out for more information, coming soon to social media, to your inboxes, and to www.isct2021.com

Sincerely,

Bruce Levine, PhD
President, 2020-2022
ISCT, International Society for Cell & Gene Therapy

ISCT 2021 Organizing Committee


Jaap Jan Boelens, MD, PhD ISCT 2021 Co-Chair Memorial Sloan Kettering Cancer Center New York, United States	Karen Nichols, Esq. ISCT 2021 Co-Chair Vertex Therapeutics Cambridge, United States	George Muschler, MD ISCT 2021 Co-Chair Cleveland Clinic Cleveland, United States

Julie Allickson, PhD
Wake Forest Institute of Regenerative Medicine
Winston-Salem, United States

Lizette Caballero, BS, MT(ASCP)
Janssen Research & Development
San Francisco, United States

Dominic Clarke, PhD
HemaCare Corporation
Durham, United States

Patrick Hanley, PhD
Children’s National Hospital
Washington, United States

Sai-Kiang Lim, PhD
Institute of Molevular & Cell Biology
Singapore, Singapore

Giuseppe Orlando, MD, PhD
Wake Forest University
Winston-Salem, United States

Patricia Rocco, MD, PhD
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil

Joseph Schwartz, MD, MPH
New York Presbyterian Hospital
New York, United States

Sandeep Soni, MD
CRISPR Therapeutics
San Francisco, United States

Jacques Galipeau, MD
University of Wisconsin-Madison
Madison, United States

Bruce Levine, PhD
University of Pennsylvania
Philadelphia, United States

Daniel Weiss, MD, PhD
University of Vermont School of Medicine
Burlington, United States

ISCT is actively monitoring the current COVID-19 pandemic and working to
expand the presentation and sponsorship opportunities for ISCT 2021.

Contact us to discuss your planning needs and stay tuned for the
release of the 2021 Corporate Prospectus and Booking form.

Madeline St. Onge
Associate Director, Marketing & Industry Affairs
Madeline@isctglobal.org

Simone Stickland
Coordinator, Outreach & Business Development
simone@isctglobal.org

ISCT 2020 Paris Virtual Showreel